About Sphingosine-1-phosphate phosphatase 1
Sphingosine-1-phosphate phosphatase 1 (SGPP1) is a protein
from Homo sapiens identified by UniProt accession
Q9BX95, 441 residues long.
MolForge cross-references it against 0 known binders and
133 disease associations.
Target properties
| Protein name | Sphingosine-1-phosphate phosphatase 1 |
| UniProt accession | Q9BX95 |
| Gene | SGPP1 |
| Organism | Homo sapiens |
| Length | 441 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (133)
Diseases linked to this target (Open Targets).
- neurodegenerative disease · score 0.30
- sphingomyelin measurement · score 0.08
- mean platelet volume · score 0.07
- colorectal carcinoma · score 0.07
- Red cell distribution width · score 0.07
- Miyoshi myopathy · score 0.07
- low density lipoprotein cholesterol measurement · score 0.07
- breast cancer · score 0.06
- serum metabolite measurement · score 0.06
- sphingolipid measurement · score 0.06
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q9BX95-F1 | alphafold | PREDICTED | 80.76 | — |
Amino-acid sequence (441 residues)
MSLRQRLAQL VGRLQDPQKV ARFQRLCGVE APPRRSADRR EDEKAEAPLA GDPRLRGRQP GAPGGPQPPG SDRNQCPAKP DGGGAPNGVR NGLAAELGPA SPRRAGALRR NSLTGEEGQL ARVSNWPLYC LFCFGTELGN ELFYILFFPF WIWNLDPLVG RRLVVIWVLV MYLGQCTKDI IRWPRPASPP VVKLEVFYNS EYSMPSTHAM SGTAIPISMV LLTYGRWQYP LIYGLILIPC WCSLVCLSRI YMGMHSILDI IAGFLYTILI LAVFYPFVDL IDNFNQTHKY APFIIIGLHL ALGIFSFTLD TWSTSRGDTA EILGSGAGIA CGSHVTYNMG LVLDPSLDTL PLAGPPITVT LFGKAILRIL IGMVFVLIIR DVMKKITIPL ACKIFNIPCD DIRKARQHME VELPYRYITY GMVGFSITFF VPYIFFFIGI S
Explore Sphingosine-1-phosphate phosphatase 1 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets